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Background: Structured education programmes are now established as an essential component to assist effective
self-management of diabetes. In the case of Type 1 diabetes, the Dose Adjustment For Normal Eating (DAFNE)
programme improves both glycaemic control and quality of life. Traditionally delivered over five consecutive days,
this format has been cited as a barrier to participation by some patients, such as those who work full-time. Some
centres in the UK have organised structured education programmes to be delivered one day a week over several
consecutive weeks. This type of format may add benefit by allowing more time in which to practice skills between
sessions, but may suffer as a result of weaker peer support being generated compared to that formed over five
consecutive days.
Methods/design: We aim to compare DAFNE delivered over five consecutive days (1 week course) with DAFNE
delivered one day a week over five weeks (5 week course) in a randomised controlled trial. A total of 213 patients
were randomised to attend either a 1 week or a 5 week course delivered in seven participating centres. Study
outcomes (measured at baseline, 6 and 12 months post-course) include HbA1c, weight, self-reported rates of severe
hypoglycaemia, psychosocial measures of quality of life, and cost-effectiveness. Generalisability was optimised by
recruiting patients from DAFNE waiting lists at each centre, and by mailing eligible patients from hospital clinic lists.
The inclusion and exclusion criteria were identical to those used to recruit to a standard DAFNE course (e.g., HbA1c
<12%, with no lower limit). Qualitative interviews were undertaken with a sub-sample of n=30 patients and their
course educators (n=11) to help understand and interpret differences and similarities in outcomes between the
two arms, and to identify logistical problems and unanticipated issues arising from the adaptation and delivery of
a 5 week course.
Discussion: This trial has been designed to test the hypothesis that the benefits of delivering a structured
education programme over 5 weeks are comparable to those observed after a 1 week course. The results of the
trial and the qualitative sub-study will both inform the design and delivery of future DAFNE courses, and the
development of structured education programmes in other fields of medicine.
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The DAFNE (Dose Adjustment for Normal Eating)
course is a 1 week structured education course teaching
skills in insulin use and dietary freedom to individuals
with Type 1 diabetes, which was originally adapted from
a German inpatient programme [1]. The original
DAFNE trial, published in 2002, demonstrated that a
dose adjustment for normal eating approach led to
improved glycaemic control and quality of life without
increases in severe hypoglycaemia, benefits which lasted
for at least 1 year [2]. DAFNE is now a nationally and
internationally delivered evidence-based, quality assured
programme [3], delivered in 76 centres across the UK
and as well as in Ireland, Australia (Oz DAFNE), New
Zealand, Kuwait and Singapore.
The development of structured education programmes,
such as DAFNE has had a major impact on the treatment
of Type 1 diabetes in the UK. The Department of Health
[4] now requires structured education programmes to be
offered to all individuals with Type 1 diabetes in England
and Wales, and most secondary care centres offer some
form of skills training to adults with Type 1 diabetes. How-
ever, the format of non-DAFNE programmes currently
offered to patients varies widely in terms of duration, num-
ber of sessions, level of quality control and designs are
not evidence based. It has been suggested that it may
not always be easy for some people to find the time to
attend an intensive 1 week course, patients cite difficul-
ties due to work obligations or arranging child-care. This
may, in part, explain the observation that around 50%
of adults with Type 1 diabetes attending centres which
run DAFNE training have not yet received this type
of education. Meanwhile, many non-DAFNE structured
education courses are delivered on a one day a week basis
for between 2 and 8 weeks [5] which may have improved
access, although in the absence of any definitive data
this is hypothetical. There has been one randomised
control trial examining the effect of a shorter period of
structured education (2.5 days) over 6 weeks in a single
centre, but no improvements in biomedical outcomes
were observed [6].
Some non-DAFNE centres have reported outcomes
during routine care in self-selected individuals which are
comparable to those reported in the original DAFNE
trial [7]. Yet, since observational data of this type are
prone to bias it is unclear whether such an extended ap-
proach to skills training is as effective as that provided
on a 1 week intensive course. This randomised controltrial is designed to test the hypothesis that the benefit of
a structured education programme, with the identical con-
tact time, is the same whether delivered over 1 or 5 weeks.
There are theoretical reasons why the two approaches
might lead to different outcomes. A 1 week model might
lead to stronger peer support developing over the week
that could help to improve incorporation of self-
management skills. Alternatively, a course delivered over
5 weeks might allow patients to gain more practice in
self-management skills during the weeks between educa-
tion sessions, thus facilitating integration of its principles
into everyday life, and hence enhance sustainability.
However, the potentially weaker peer support on a 5 week
course may lead to a higher drop-out rate, with less parti-
cipants completing the full 5 days of skills training.
Establishing whether DAFNE delivered at weekly inter-
vals is as effective as delivering it over 5 consecutive days
will help guide and inform decisions about future course
delivery. Potentially it could also allow more individuals
with Type 1 diabetes to receive structured education and
increase patient choice. As qualitative work can provide
important insights into trial outcomes [8], a qualitative
sub-study was conducted in which we drew upon people’s
understandings and experiences, by interviewing both
educators and course participants. We also surveyed parti-
cipants at the end of the trial asking whether they would
prefer future structured education programmes to be
delivered over 1 week or a more extended period of 5
weeks. Included in this survey were questions enquiring
as to current self-management strategies.
Methods/design
The DAFNE 5x1 day RCT is a multi-centre randomised
trial comparing 2 different methods of delivering the
DAFNE programme in the UK.
The objectives:
1) To explore whether the outcomes of a structured
education programme with identical contact time are
comparable whether delivered over 1 or 5 weeks.
2) To examine the cost effectiveness of a DAFNE
course delivered either over 1 or 5 weeks.
3) To calculate how many patients choose to receive
structured education programmes over 1 or 5 weeks,
by conducting a preference survey.
4) The aims of the qualitative sub-study were
a) Help understand and interpret any differences and
similarities in biomedical and psychological
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courses delivered over 1 or 5 weeks.
b) Identify any logistical problems and unanticipated
issues arising from the adaptation and delivery of
DAFNE as a course spread over 5 weeks.
5) Provide recommendations for the timing, content
and delivery of future DAFNE courses.
Ethical approval was obtained from the Derbyshire
Research Ethics Committee (09/H0401/91). Written
informed consent was obtained from all trial participants,
after they had had sufficient time to consider the Patient
Information Sheet and had any questions pertaining to
the trial answered. Additional written informed consent
was obtained from participants in the qualitative sub-
study. The study is registered with the local Research and
Development department of each study centre and Shef-
field Teaching Hospitals NHS Foundation Trust is acting
as the sponsor.
Funding was secured as part of a NIHR programme
grant for applied research – Improving management of
Type 1 diabetes in the UK: the DAFNE programme as a
research test-bed (application number RP-PG-0606-1184).
Recruitment procedures
Secondary care centres with experience in delivering
high quality structured education using DAFNE parti-
cipated in the trial. When invited in 2009, seven out
of a possible 74 DAFNE centres volunteered to take
part. All eligible participants on the DAFNE waiting
list received a written invitation to join the study from
their local diabetes team. After indicating initial interest
they were contacted by a member of the local research
team or educator who provided further information,
which, in some centres, included an invitation to an
information evening, prior to obtaining informed con-
sent. Participants were informed of a pair of course
dates (a one week and a 5 week course) for which
they would need to be available. After obtaining con-
sent, the participants were randomised to either attend
one or other format of course, i.e., either a 1 week or 5
week course. Recruitment took place between May 2010
and April 2011. When consent was obtained, patients
were also asked to indicate whether their contact details
could be made available to the qualitative research team
in order that they might be approached to take part in
the qualitative sub-study. Those who were approached
were given further written information about the qua-
litative study and asked to opt-in using a separate con-
sent form.
The inclusion criteria were as follows: Adults with
Type 1 diabetes for at least 6 months, aged 18 – 80 y,
HbA1c <12%, willing to undertake intensive insulin ther-
apy, with multiple self-monitoring of blood glucose(SMBG), carbohydrate counting, insulin self-adjustment
and no strong views on attending a 1 week course or
a 5 week course. Participants needed to agree to random-
isation regardless of preference, having not yet completed
DAFNE training or equivalent.
The exclusion criteria were as follows: severe diabetic
complications (these include renal replacement therapy,
severely impaired vision), inability to communicate in
English, strong preference for either a 1 week or a 5 week
course, severe needle phobia, unenthusiastic about
undertaking SMBG and insulin self-adjustment, or in-
ability to give informed consent.
Sample size
Using a non-inferiority design, and based on clinically
relevant difference of HbA1c of 0.5%, a standard devia-
tion of 1.5 and groups of 7–8 participants per random-
isation group, for 80% power at one-sided 5%
significance 150 participants were required to complete
the study procedures. Allowing for a 10% drop-out from
randomisation to completion of the trial, it was antici-
pated that we would require 166 subjects to be rando-
mised in the study. Thus we aimed to run 24 courses
(12 courses per arm). Each centre was required to re-
cruit 32 patients to enable 4 courses (two standard
DAFNE and two 5 week) to be run with 8 participants
on each. However, during the recruitment phase of the
trial it became apparent that the drop-out rate between
randomisation and course participation was higher than
had been anticipated, at over 11%, hence one centre ran
an extra pair of courses.
The flow of patients through the trial is shown in
Figure 1, this figure follows the CONSORT approach,
as will future reporting of the trial results [9].
Randomisation
After consent and completion of baseline data collec-
tion, the participants were individually randomised using
a random block size, stratified by centre and a web-
based remote randomisation system into either a 1 week
course or a 5 week course. The allocation sequence was
generated by MJC using a computer program called
RANDOLOG (University of Southampton). The centres
sent a list of participant study numbers to CE, the project
manager, who performed the blinded randomisation and
informed the centres of the results.The intervention
Patients were randomised to either:
 1 week - The standard DAFNE 1 week course, or
 5 weeks - The DAFNE course delivered on one day
a week over 5 consecutive weeks
Assessed for eligibility
(n=217)
Excluded as did not meet  
inclusion criteria (n=4)
Randomised
(n=213)
Allocated to 1 week 
course (n=101)
Allocated to 5 week 
course (n=112)
Attended 1 week 
baseline data collection 
(n=89)
Attended 5 week 
baseline data collection 
(n=99)
Failed to attend 
baseline (n=12)
Failed to attend 
baseline (n=13)
Dropped out prior 
to course (n= 6)
Dropped out prior 
to course (n= 2)
Commenced 1 week 
course (n=83)
Commenced 5 week 
course (n=97)
Excluded as
HbA1c>12% (n= 2)
Excluded as 
HbA1c>12% (n= 2)
Excluded as 
HbA1c>12% (n= 1)
Dropped out during 
course (n= 1)
Dropped out during 
course (n= 7)
Per protocol 1 week 
course (n=80)
Per protocol 1 week 
course (n=88)
Lost tofollow-up 
(n=5)
Lost tofollow-up 
(n=3)
1 week intervention 
analysed per protocol 
(n=75)
5 week intervention 
analysed per protocol 
(n=85)
Figure 1 Flow diagram of the participant progress through the phases of the 5x1 randomised control trial.
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duce bias, each Centre’s 1 week and 5 week courses were
delivered by the same two DAFNE educators, so that the
skills, enthusiasm or teaching style of an educator did
not favour one arm over the other. As defined for stand-
ard DAFNE courses, a participant was deemed to have
completed the course if they attended for at least 4 full
days of the 5 day course. Where a participant missed a
day, attempts were made by the educators to cover
missed material on an individual basis also as per nor-
mal DAFNE procedures. If a course could not be filled
with trial participants, individuals undergoing DAFNE
training but not consented to the trial (‘fillers)’ were
included so as to maintain the normal dynamics of
DAFNE group education.1 week - The standard DAFNE 1 week DAFNE course
Each course took place over five consecutive days and
was delivered to groups of 5–8 adults. The curriculum
uses a progressive modular based structure to improve
self-management in a variety of medical and social situa-
tions. The curriculum is designed to deliver key learning
topics at the appropriate time within the programme. In
this way, knowledge and skills are built up throughout
the week with active participant involvement and prob-
lem solving as key methods of learning. The key mo-
dules are: what is diabetes; food and diabetes; insulin
management; management of hypoglycaemia; sick day
rules. Learning objectives for each day and each session
are clearly identified and educators have instructions on
session preparation and teaching materials. Lesson plans
Elliott et al. BMC Endocrine Disorders 2012, 12:28 Page 5 of 9
http://www.biomedcentral.com/1472-6823/12/28give guidance on timing and a student activity section
serves to give an idea of expected responses. Each meal
and snack is used as an opportunity to practise carbohy-
drate estimation and insulin dose adjustment.
5 weeks - The DAFNE course delivered on one day a week
over 5 consecutive weeks
The curriculum was adapted from the standard course
described above. This process was informed by qualita-
tive interviews performed during an earlier mixed me-
thods study of the DAFNE programme, in which patient
and educator views were solicited as to how the curricu-
lum could be adapted for a 5 week course. Four expe-
rienced DAFNE educators met with the qualitative
researchers to exchange ideas and then further refine-
ments were communicated within the group via e-mail.
The contents of the two curricula were identical in terms
of educational content and skills training although we
made some minor changes to accommodate the needs of
those attending over 5 weeks. Thus rather than providing
a workbook on each day of the course, those attending 1
week courses received an entire workbook at the outset.
The hope was that this would encourage participants to
attend each week to gain more information and thereby
reduce the drop-out rate. Also, blood glucose diaries
were modified to allow for additional space to record to
events / physical activity in more detail. The adapted
curriculum was tested in 3 pilot courses, at 2 different
centres, prior to commencement of the main trial. As a
result of the pilot courses minor modifications were
made to two of the sessions.
Follow up
Patients attending both 1 week and 5 week courses were
invited to a 6 week post course group-based meeting last-
ing 1–2 hrs to review DAFNE principles (a standard
practice for regular DAFNE course attendees). At 6 and
12 months post the last day of the course, both groups
were due to attend for measurement of weight, recording
of hypoglycaemic episodes, collection of blood for HbA1c
and blood biochemistry, and completion of psychosocial
questionnaires. Interviews for the qualitative sub-study
were conducted during the week after courses had
concluded, with follow-up interviews six months later.
Outcomes
We measured outcomes on two occasions primarily to
examine the time of maximum effect, and also because
repeated measures improves the power to test the main
objective.
The Primary outcome was:
Change in HbA1c from baseline at 6 and 12 months.
HbA1c, a measurement of glycosylated haemoglobin, is
regarded as the gold standard measure of glycaemiccontrol reflecting overall blood glucose values over the
previous 8–12 weeks. There is a strong relationship
between HbA1c and the risk of developing long-term
diabetic complications and it is accepted as a reasonable
surrogate for long-term outcomes in individuals with
diabetes. HbA1c was measured at local laboratories
DCCT aligned (as per Diabetes Control and Complications
Trial [10]).
The Secondary Outcomes were:
Change in HbA1c from baseline at 6 and 12 months
for those with a baseline HbA1c ≥7.5%, This is because
some of the participants with low HbA1cs would be
aiming to reduce the number of episodes of hypoglycaemia,
as opposed to further reducing their HbA1c.
Biomedical: eGFR, and lipids (including HDL choles-
terol), using local labs at baseline and 12 months as part
of routine clinical monitoring.
Hypoglycaemia: Number of episodes of severe
hypoglycaemia using a standard definition of an episode
leading to cognitive impairment sufficient to cause either
coma or requiring the assistance of another person to
recover. (The number of severe episodes is considered
to be reliably recalled by patients for up to 1 year. [11])
Psychosocial:
 Quality of life: Quality of life (QoL) is assessed using
both the diabetes-specific quality of life scale
(DSQOLS [12]), and the generic measures of QoL,
SF-12 [13], and EQ-5D [14].
 Emotional Well-being: is assessed using the Hospital
Anxiety and Depression Scale (HADS; [15]), the
diabetes-specific Problem Areas in Diabetes Scale
(PAID [16]).
 Self-efficacy: Diabetes-specific self-efficacy is
assessed using the Confidence in Diabetes Self-Care
measure [17] a validated, reliable measure for people
with type 1 diabetes.
 Thoughts about Diabetes [Personal Models of
Diabetes [18,19]: This assesses beliefs about the
seriousness of diabetes and treatment effectiveness.
It is validated for use with adults with diabetes [20].
 Self-Care Behaviours: The revised Self-Care
Inventory, a measure of perceived adherence to
diabetes self-care recommendations [21].
 Fear of Hypoglycaemia Questionnaire (Worry
subscale; [22]). This scale and the one below
assesses the influence of these concerns on
self-management and quality of life. Both scales have
established validity and reliability in this patient
population.
 Fear of Complications Questionnaire [23].
 Social Support Questionnaire [24,25]: The SSQ6 is
an abbreviated version of the original 27-item
questionnaire. It provides a measure of the number
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indication of the level of satisfaction with that
support. It has high internal consistency and
re-test reliability [26].
 A single-item measure of life satisfaction from the
Personal Well-Being Index [27].
 Diabetes Knowledge Questionnaire – Revised
Michigan Diabetes Knowledge Questionnaire [28].
 Evaluation of the DAFNE course is assessed at 6
weeks using one, 9-item sub-scale of the Health
Education Impact Questionnaire [29].
 Adherence to DAFNE principles: This is assessed at
the 6 week, 6 and 12 month follow ups using a
DAFNE specific Self-Management questionnaire,
developed for the present NIHR Psychosocial study,
(MREC 08/H0808/53).
Analysis
The primary analysis will be a linear model of HbA1c
at 12 months with baseline HbA1c as a covariate,
(which will improve the power relative to the predicted
power), using generalised estimating equations (GEE) to
control for clustering within courses. The intracluster
correlation coefficient coefficient (ICC) will be esti-
mated using the method of moments. Poisson regres-
sion (or a zero-inflated Poisson regression if necessary)
will be used on the number of hypoglycaemic episodes
over 12 months, which should also have more power
than a dichotomy of having/not experiencing an epi-
sode, again using GEE to account for clustering. We will
use an intention to treat analysis, but will explore the
issue of participants dropping out using multiple impu-
tations. The full analysis set (FAS) for the intention to
treat analysis includes all patients for whom baseline
data was collected. A per protocol analysis will also be
performed.
Health economics analysis
An economic evaluation will be undertaken from the
NHS perspective, using both a within trial timeframe
and a modelled patient lifetime timeframe. The modelled
analysis will be the primary focus of the economic sub-
study. Patient costs will be calculated covering training,
equipment, drugs and NHS contacts relating to the
management of diabetes and its associated conditions.
The cost of the training associated with the control and
intervention groups will be calculated through a survey
of resource use and costs at each of the seven recruiting
centres. The survey will cover staff input, consumables,
capital and overheads, and will be followed up with dis-
cussions with staff at each centre to ensure the quality of
information provided.
Patient-level data will be collected for equipment,
drugs and NHS contacts. Equipment and drug use willbe taken from the trial’s clinical record forms, while the
NHS contacts will be taken from the DAFNE Pro-
gramme’s patient database. This database records all
primary care contacts relating to diabetes, specific contacts
for hypoglycaemic events, and diagnosis-specific inpatient
admissions.
Unit costs will be taken from standard sources (NHS
Reference Costs, British National Formulary, and
PSSRU). Quality adjusted life years (QALYs) will be esti-
mated using EQ-5D at baseline, 6, and 12 months, and
patient mortality.
Two analyses, one within the trial, and another using a
lifetime analysis based on the Sheffield Type 1 Diabetes
Policy Model (currently in development through the
NIHR Programme Grant), will be undertaken. An incre-
mental cost effectiveness ratio (ICER) will be calculated
with uncertainty around this characterised by plots on
the cost-effectiveness plane and its associated cost-
effectiveness acceptability curve. The impact of different
training costs as observed in the different centres will be
assessed using one-way sensitivity analysis.
Qualitative sub-study
Background
Prior to development of the 5x1 trial, as part of the
NIHR programme, a qualitative evaluation had already
been undertaken of standard DAFNE courses delivered
over one week to understand and explore patients’ likes
and dislikes of their courses, and their reasons for follow-
ing or not following a DAFNE regimen post-course and
over time. This qualitative evaluation comprised observa-
tion of six DAFNE courses and in-depth interviews with
patients (n=30) on completion of their courses and six
and 12 months later. Twelve educators were also inter-
viewed. Findings from this work have already been pub-
lished [30-34] with further papers planned. As we had
already collected detailed data on participants’ expe-
riences of, and views about, one week DAFNE courses
and their post-course experiences, we decided to focus
on the 5 week course participants in the 5x1 trial, and
to compare their data to that already collected during
the qualitative evaluation of the one week DAFNE
courses. The inclusion of this qualitative work in the
5x1 trial follows the NICE recommendation that ran-
domised controlled trials involving diabetes educational
interventions should involve a qualitative evaluation of
the intervention [35].
Research questions
1) Are there any differences in the ways in which
patients interact with, and support one another,
when attending a DAFNE course delivered over 1
or 5 weeks, and why?
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changes to their insulin doses and approach to
diabetes management during and after attending a
course delivered over 1 or 5 weeks, and why?
3) Do any logistical and/or unanticipated issues arise
from the adaptation and delivery of a DAFNE course
spread over 5 weeks?
4) If any patients withdraw from the 5 week course,
what are their reasons for doing this?
5)What do patients and educators like/dislike about
attending/delivering a DAFNE course for one day a
week over five weeks? What are the perceived
advantages and disadvantages of a DAFNE course
delivered over 5 weeks rather than over 1 week?
What are patients’ preferences for the timing of
DAFNE courses, and why?
6) How can the findings relating to the above research
questions be used to explain differences/similarities
in biomedical and psychological outcomes between
patients attending the two types of courses?
Study design
1) Observation of five week DAFNE courses to: (a)
inform issues and areas explored in interviews with
patients and educators who participated in these
courses;(b) ascertain, through comparison with
observational data collected during the evaluation of
standard courses delivered over one week, whether
there are any differences between the two types of
course (e.g. in terms of style, curriculum delivery,
individual and group dynamics); and, (c) identify any
unanticipated issues arising from the adaptation and
delivery of DAFNE courses over five weeks.
2) Post-course interviews with patients to: explore their
experiences of, and views about, the DAFNE course
spread over five weeks; any changes they have made
to their diabetes management/self-care practices in
light of the course (and why); their hopes,
expectations and (any) short- and long-term
treatment goals set; and (if relevant), reasons for not
completing the course.
3) Follow-up interviews with patients at six months to
explore whether, and why, they have been able or
unable to sustain their skills training in intensive
insulin therapy, and any issues which they think may
help promote/support effective self-management in
the future.
The time-point for follow-up interviews was selected
(a) to mirror the design of the qualitative evaluation
of the standard courses delivered over one week and
(b) because this evaluation had highlighted that, by
six months, sufficient time should have elapsed to
establish whether, and for what reasons, patients areable/unable to put their skills training into practice
and sustain the intensive approach to disease
self-management taught on their courses.
To contextualise and enhance understanding of
patients’ accounts, other issues were also explored in
their initial and follow-up interviews including: work
and family commitments and the impact and
implications of these for treatment adherence, course
attendance, and course preferences etc.; (changing)
perceptions and understandings of their disease
(e.g. perceived seriousness and controllability); and,
their experiences of, views about, and need for health
professional and other forms of support prior and
subsequent to course attendance.
4) Interviews with educators on completion of courses
to reflect upon their understandings and experiences
of course delivery; their perceptions and views of
(any) differences; issues and/or challenges arising
from delivering DAFNE over five weeks rather than
over one week; and, recommendations for future
course development.
Data collection
Observational data were recorded in the form of field
notes and written up by DR at the end of each day of sit-
ting in on the DAFNE course. Topic guides have been
used to inform all interviews to ensure the discussion
stays relevant to the study aims and objectives, while
allowing participants to raise and discuss issues they
perceive as salient to them. These were adapted from
those used in the qualitative evaluation of standard
DAFNE courses delivered over one week to allow for
data comparisons.
Baseline interviews with patients were normally under-
taken face-to-face and at a time and location of their
choosing (normally in patients’ own homes). Follow-up
interviews were undertaken on the phone unless a pa-
tient requested a face-to-face interview. Educator inter-
views were undertaken by phone.
Each patient and educator interview lasted around an
hour, and, subject to consent, these were audio-recorded,
and transcribed in full to permit in-depth analysis.
Sample
Four 5 week courses were observed in their entirety, in
three trial centres. The sample size of n=30 patients was
determined, based on previous experience [36,37], to en-
able a diversity of perspectives to be examined, a full
range of issues to be explored, data saturation to occur
(i.e. no new findings emerge from an analysis of new
data), and for meaningful comparisons to be drawn be-
tween the experiences and views participants on the two
types of courses. Initial data collection was staggered
over 7 months to allow for issues and findings arising
Elliott et al. BMC Endocrine Disorders 2012, 12:28 Page 8 of 9
http://www.biomedcentral.com/1472-6823/12/28during the early phases of data collection to inform, if
necessary, the areas explored in later stages of data col-
lection, in line with an inductive thematic approach.Data analysis
Using an ongoing and iterative process data analysis
started once the observations and interviews began. The
study was informed by the principles of grounded theory
[38] and the method of constant comparison [39], which
involves concurrent data collection and analysis, together
with systematic efforts to check and refine developing
categories of data. Data collection stopped in October
2011 and data analysis is currently on-going. Data are
being analysed thematically and the two datasets (i.e. one
week and five week participant accounts) are being
cross-compared to look for differences and similarities in
course participants’ experiences, views, course prefer-
ences and self-management approaches post course and
over time, and the reasons for these. Regular meetings
(between JL and DR) are taking place to explore partici-
pants’ underlying reasoning, discussion of deviant cases
and agreement on recurrent themes and findings. NVivo
9, a qualitative data-indexing package is being used to
facilitate coding and retrieval.Discussion
A particular strength of this trial is that it has not oc-
curred in isolation, but as one component of a NIHR 5
year programme grant utilising DAFNE as a research
test-bed. Professionals from different disciplines have
collaborated on other pieces of work within this grant,
thus the development of the intervention and conduct of
the trial has been informed and influenced by other
facets of the research programme. One such element
was a psychosocial evaluation of how, and why, in the
context of Type 1 diabetes in the UK, structured group
education actually works [30-34]. By incorporating quali-
tative substudies within the programme grant we have
aimed to enhance and inform interpretation of findings
and recommendations for future delivery of structured
education.
The trial has also highlighted some of the problems
involved in conducting a non-pharmaceutical funded
clinical trial within the NHS. Each centre has relied
largely on the goodwill of one or two DAFNE educators,
a part-time administrator, plus a consultant physician to
recruit participants into the trial and to collect follow-up
data. The scale of this latter process cannot be under-
estimated, and has been aided in some centres by help
from their local CLRN (Clinical Research Network). The
programme grant only included a relatively small pay-
ment to be made to each centre for running the courses
and for entering data (£1250 / course). Development ofthe five week curriculum, and production of resources
was aided by the DAFNE Collaborative.
Data collection is due to be complete by Summer
2012, the results will be analysed by our statistical team,
and we hope to publish findings from this randomised
controlled trial shortly thereafter.
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